CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Change in Management
Resignation of Senior Management Personnel14-05-2024
14-05-2024
Cipla keen on obesity segment, to bring out products on its own or though partnership
Profit after tax was up 79 per cent in Q4 at at 939 crore10-05-2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the audio recording of the earnings conference call for Q4 FY 24.10-05-2024
Q4FY24 Quarterly & FY24 Annual Result Announced for Cipla Ltd.
Pharmaceuticals company Cipla announced Q4FY24 & FY24 results: FY24 Financial Highlights: For the fiscal year 2024, Cipla's annual revenue surpassed Rs 25,000 crore with a growth of 14% YoY, while the Profit After Tax (PAT) soared by an impressive 47% YoY to Rs 4,106 crore. Q4FY24 Financial Highlights: For Q4FY24, Cipla's revenue was Rs 6,163 crore with a growth of 10% YoY, while the Profit After Tax (PAT) soared by an impressive 79% YoY to Rs 939 crore. Umang Vohra MD and Global CEO, Cipla, said “I am pleased to share our performance for the year where we made substantial progress across our focused markets. In FY24, our revenues crossed the threshold of Rs 25,000 crore whereas operating margins significantly improved to cross Rs 6,000 crore for very first time, growing at healthy 14% on topline and 26% on profitability YoY. This was backed by One-India revenue breaching Rs 10,000 crore, North America revenue surpassing USD 900 million and South Africa reaching top spot in prescription market, with all three businesses growing in double digits over last year with improved profitability. As we enter into FY25, our focus will be on our priorities of market leading growth in our key markets, growing big brands bigger, investing in future pipeline as well as focusing on resolutions on regulatory front”. Result PDF10-05-2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication10-05-2024
CIPLA LTD. - 500087 - Record Date For Payment Of Final Dividend For FY 2023-24
Record date for payment of final dividend for FY 2023-2410-05-2024
CIPLA LTD. - 500087 - Grant Of Stock Options And Employee Stock Appreciation Rights
Grant of Stock options and employee stock appreciation rights10-05-2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation for Q4 & FY24 financial results10-05-2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for Q4 & FY24 financial results10-05-2024